Steven Boyd, Armistice

Steven Boyd, Armistice Capital Ranked #2 in Rising Hedge Fund Stars (Institutional Investor Magazine).

A handful were born outside the U.S., while others are first-generation Americans. Some were shoo-ins for the Ivy League, while several relied on athletic...

Internet Stock Review Initiates Coverage On HealthLynked Corp. (HLYK) $0.23.

NAPLES, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced it has retained Institutional Analyst Inc., to provide coverage to investors...
Biotech Stock Review, Dicerna DRNA

Adding Dicerna (DRNA) $3.30 to Watch List.

Adding Dicerna (DRNA) $3.30 to Watch List. How fun would it be to sell a $3.00 idea (IMMU) at $9.00 you got from us and...
Biotech Stock Review

Adding Immunomedics (IMMU) $3.00 to Watch List.

Biotech Stock Review Initiates Coverage. Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears. As posted on SeekingAlpha.

Largest Stem Cell Investor Conference Set to Be Held in New York City

Where Stem Cell Science, Meets Wall Street NEW YORK, NY--(Marketwired - Oct 6, 2015) - Investor Conference Network will be holding what many are calling...
Roland Rick Perry, Biotech Stock Review

CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground Running.

“Announces Partnership With Caron Foundation, Ranked Amongst Top 7 Treatment Centers in US with Revenues Approaching $100 million.” On August 20th CNS-Wellness, a wholly owned...
zestra, biotech stock review

Innovus (INNV) Zestra® Female Sexual Arousal Oils Featured in NY Times.

Erin Drought, a 28-year-old information technology consultant in Edmonton, Alberta, who says her sex drive evaporated after she began taking medicine for bipolar disorder,...
Biotech Stock Review

Christopher E. Rivera Appointed to the Council of Washington Biotechnology & Biomedical Association

WASHINGTON, DC and SEATTLE, WA – (June 27, 2011) – Today the Washington Biotechnology & Biomedical Association (WBBA) and the Biotechnology Industry Organization (BIO)...

Latest article

Fusion Energy Starter.

VC-Funded Fusion Energy Companies "The fastest way to deploy fusion and I believe one of my forecasts is we will replace every coal and natural...

Party Time at UniQure (QURE)! From $8.86 to $47.21, up 432%.

I. No Bells, No Baskets. UniQure (QURE) $47 up Huge. Still Not Out Of The Woods! II. Replimune (REPL) $11.23. Gains 28% in Sympathy with...

We’re Up 360% in Six Weeks. Replimune (REPL).

That's a Gain of $604 Million, and That Ain't Bad! Six brokerage firms downgraded Replimune (REPL), around the same time we added it to...